Healthpeak Properties (NYSE:DOC) Announces Quarterly Earnings Results
by Jessica Moore · The Cerbat GemHealthpeak Properties (NYSE:DOC – Get Free Report) released its quarterly earnings results on Tuesday. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02, Zacks reports. Healthpeak Properties had a return on equity of 2.67% and a net margin of 7.73%.The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same quarter last year, the business posted $0.46 earnings per share. Healthpeak Properties’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties updated its FY 2026 guidance to 1.710-1.750 EPS.
Healthpeak Properties Trading Down 2.3%
Shares of NYSE DOC traded down $0.45 during midday trading on Thursday, hitting $19.06. The stock had a trading volume of 1,252,122 shares, compared to its average volume of 9,107,141. The company has a market capitalization of $13.25 billion, a price-to-earnings ratio of 59.72, a PEG ratio of 2.28 and a beta of 1.00. Healthpeak Properties has a 1-year low of $15.70 and a 1-year high of $19.68. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The company has a fifty day moving average price of $16.97 and a 200 day moving average price of $17.15.
Healthpeak Properties Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s payout ratio is currently 381.25%.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on DOC. Morgan Stanley decreased their price objective on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 28th. UBS Group started coverage on Healthpeak Properties in a report on Monday, April 20th. They set a “neutral” rating and a $17.00 price objective on the stock. Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday, May 2nd. The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They issued a “neutral” rating and a $17.00 target price on the stock. Finally, Citigroup dropped their price target on shares of Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating for the company in a research report on Wednesday, April 1st. Five analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $18.04.
Check Out Our Latest Research Report on DOC
Hedge Funds Weigh In On Healthpeak Properties
Several hedge funds and other institutional investors have recently modified their holdings of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Healthpeak Properties by 235.3% in the 4th quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock valued at $56,477,000 after purchasing an additional 2,464,612 shares in the last quarter. Bank of America Corp DE lifted its stake in shares of Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after purchasing an additional 2,206,222 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in shares of Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.